SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Meghmani Finechem - Quaterly Results

24 Jan 2022 Evaluate
The topline for the December 2021 quarter moved up 90.59% to Rs. 4221.74 millions as compared to Rs. 2215.09 millions during the year-ago period.The Net Profit of the company vaulted to 183.77% to Rs. 697.34  millions from Rs. 245.74 millions in the previous quarter.Operating profit for the quarter ended December 2021 rose to 1410.71 millions as compared to 690.47 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202112 202012 % Var
Sales 4221.74 2215.09 90.59 4221.74 2215.09 90.59 4221.74 2215.09 90.59
Other Income -2.96 6.49 -145.61 -2.96 6.49 -145.61 -2.96 6.49 -145.61
PBIDT 1410.71 690.47 104.31 1410.71 690.47 104.31 1410.71 690.47 104.31
Interest 103.56 110.86 -6.58 103.56 110.86 -6.58 103.56 110.86 -6.58
PBDT 1307.15 579.61 125.52 1307.15 579.61 125.52 1307.15 579.61 125.52
Depreciation 218.15 212.50 2.66 218.15 212.50 2.66 218.15 212.50 2.66
PBT 1089.00 367.11 196.64 1089.00 367.11 196.64 1089.00 367.11 196.64
TAX 391.66 121.37 222.70 391.66 121.37 222.70 391.66 121.37 222.70
Deferred Tax 192.59 56.91 238.41 192.59 56.91 238.41 192.59 56.91 238.41
PAT 697.34 245.74 183.77 697.34 245.74 183.77 697.34 245.74 183.77
Equity 415.50 415.53 -0.01 415.50 415.53 -0.01 415.50 415.53 -0.01
PBIDTM(%) 33.42 31.17 7.20 33.42 31.17 7.20 33.42 31.17 7.20

Epigral Share Price

1199.60 7.15 (0.60%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3649.20
Tata Chemicals 694.10
SRF 2493.90
Pidilite Inds. 1394.35
Deepak Nitrite 1690.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×